Fonar CorpNASDAQ:FONR
- LAST PRICE15.8500
- TODAY'S CHANGE (%)0.0700 (0.4436%)
- Bid / Lots15.7800/ 2
- Ask / Lots16.0700/ 1
- Open / Previous Close15.7300 / 15.7800
- Day Range
- 52 Week Range
- Volume11,120
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | FONR |
|---|---|---|
| 09:32 ET | 604 | 15.73 |
| 09:48 ET | 296 | 15.885 |
| 09:54 ET | 800 | 15.99 |
| 10:01 ET | 100 | 15.94 |
| 10:03 ET | 600 | 15.822 |
| 10:15 ET | 800 | 15.806 |
| 10:28 ET | 800 | 15.8 |
| 10:39 ET | 100 | 15.82 |
| 12:03 ET | 2360 | 15.95 |
| 12:05 ET | 348 | 15.95 |
| 01:30 ET | 500 | 15.905 |
| 01:48 ET | 200 | 15.9 |
| 02:08 ET | 216 | 15.95 |
| 02:15 ET | 759 | 15.95 |
| 03:38 ET | 212 | 15.9101 |
| 03:43 ET | 100 | 15.905 |
| 03:56 ET | 100 | 15.81 |
| 03:59 ET | 221 | 15.85 |
Today
FONAR Announces Financial Results for Fiscal 2023, from 16 hours ago by Dow Jones
16 hours ago by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Fonar Corp | 109.2M | 11.4x | -9.70% |
Medigus Ltd | 55.7M | -0.7x | --- |
Venus Concept Inc | 11.1M | -0.2x | --- |
Standard BioTools Inc | 225.8M | -2.7x | --- |
ViewRay Inc | 1.6M | 0.0x | --- |
Vaso Corp | 57.8M | 4.4x | --- |
Company Information
Fonar Corporation is engaged in the research, development, production and marketing of magnetic resonance imaging (MRI) for the detection and diagnosis of human diseases. The Company operates through two segments: manufacturing and the servicing of medical equipment and management of diagnostic imaging centers. It offers Upright MRI, which is used to scan any part of the body. The Upright MRI allows patients to be scanned in various conditions, such as standing, sitting, bending or lying down in any position. The Company’s products and services include the FONAR 360° and the OPEN SKY MRI.
Contact Information
- Headquarters
- 110 Marcus DrMELVILLE, NY, United States 11747-4228
- Phone
- 631-694-2929
- Fax
- 631-753-5150
Executives
- Chairman of the Board, President, Chief Executive Officer, Treasurer
- Timothy Damadian
- Executive Vice President, Chief Operating Officer, Acting Principal Financial Officer
- Luciano Bonanni
- Secretary, Director
- Claudette Chan
- Lead Independent Director
- Ronald Lehman
- Independent Director
- Jessica Maher
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $109.2M |
|---|---|
Revenue (TTM) | $97.7M |
Shares Outstanding | 6.9M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 0.89 |
EPS | $1.39 |
Book Value | $21.67 |
P/E Ratio | 11.4x |
Price/Sales (TTM) | 1.1 |
Price/Cash Flow (TTM) | 6.2x |
Operating Margin | 16.84% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
